Ledger.Open graph →
SEC Form D · filed November 25, 2014

N30 Pharmaceuticals, Inc

Offering
$40.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOULDER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Joseph Loscalzo · Boulder, CODirectorJonathan Leff · South San Francisco, CADirectorTom Sokolowski · Boulder, COExecHoward Furst · Boulder, CODirectorEvan Loh · Boulder, CODirectorJohn Moore · Wilmington, DEDirectorJoseph Loscalzo · Boulder, CODirectorJonathan Leff · San Francisco, CADirectorTom Sokolowski · Boulder, COExecHoward Furst · Boulder, CODirectorEvan Loh · Boulder, CODirectorJohn Moore · Boulder, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗